Lv11
16 积分 2024-03-28 加入
Clinical Pharmacology Profile of AMG 119, the First Chimeric Antigen Receptor T (CAR‐T) Cell Therapy Targeting Delta‐Like Ligand 3 (DLL3), in Patients with Relapsed/Refractory Small Cell Lung Cancer (SCLC)
2小时前
待确认
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
10小时前
已完结
Yeast surface display platform for rapid discovery of conformationally selective nanobodies
2个月前
已完结
Development of anti-matrix metalloproteinase-2 (MMP-2) nanobodies as potential therapeutic and diagnostic tools
3个月前
已完结
Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: A prospective study
3个月前
已完结
Inhibition of angiogenesis in human endothelial cell using VEGF specific nanobody
5个月前
已完结
Bispecific killer cell engager-secreting CAR-T cells redirect natural killer specificity to enhance antitumour responses
5个月前
已完结
NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma
6个月前
已完结
Engineering multi-specific nano-antibodies for cancer immunotherapy
6个月前
已完结
皖公网安备34019202002308
